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INTRODUCTION
IgG4-related autoimmune disease is a recently recognized 
clinical entity associated with autoimmune pancreatitis, 
various systemic extrapancreatic lesions and an elevated 
serum IgG4 level.
1 IgG4-related sclerosing cholangitis 
(IgG4-SC) is one of the extrapancreatic manifestations of 
this entity, which needs to be differentiated from primary 
sclerosing cholangitis (PSC) as these two diseases appear 
similar at presentation, but follow different clinical courses. 
In this issue, we will discuss the histopathologic findings of 
IgG4-SC based on a liver biopsy case of a 65-year-old patient 
with autoimmune pancreatitis. 
CASE SUMMARY
A 65-year-old previously healthy male presented with 
sharp epigastric pain and fever for the past two days. He had 
received a pylorus-preserving pancreaticoduodenectomy 
under the impression of a distal common bile duct cancer 3 
years ago. He had a smoking history of 40-packs per year 
and a recent history of alcohol ingestion before surgery. 
Initial aspartate aminotransferase and alanine aminotransferase 
levels were 147 IU/L and 150 IU/L, respectively. The initial 
laboratory data showed an increased white blood cell count 
(13,300/μL) and C-reactive protein level (5.3 mg/dL). Serologic 
markers for hepatitis B surface antigen (HBsAg), IgM anti-HBc, 
IgM anti-hepatitis A virus antibody, and anti-hepatitis C 
virus antibody were all negative. Tumor markers and anti- 
nuclear antibody were also negative. Abdominal computed 
tomography and ultrasonography demonstrated a soft tissue 
infiltration around the common hepatic duct with bile duct 
dilatation and an ill-defined thickening of the bile duct wall 
at the hilar portion, suggestive of IgG4-SC. Serum IgG4 level 
was increased up to 196 mg/dL, and the serum IgG4/IgG 
ratio was 16.6%. A needle biopsy of the liver was performed. 
PATHOLOGIC FINDINGS
Microscopic evaluation of liver biopsy revealed moderate 
inflammatory cell infiltrates in a few portal tracts (Fig. 1A, 
1B). The inflammatory cells comprised lymphocytes, plasma 
cells and eosinophils. The infiltration was mainly centered 
around the portal veins with endothelial damage. The hepatic 
arteries and bile ducts were spared by the inflammatory 
infiltrates and degeneration of bile duct epithelial cells was 
not identified. Mild ductular reaction was seen in at the 
portal-parenchymal interface. The portal fibrosis was mild, 
and there was no evidence of an ‘onion-skin’ pattern. The 
lobular inflammatory infiltrate was mild. Immunohisto-
chemical stain revealed a few portal tracts containing up to 
12 IgG4-positive plasma cells per high-power microscopic 
field (Fig. 1C). 
The previously resected pancreas demonstrated a dense 
lymphoplasmacytic infiltrate affecting the parenchyma with 
septal fibrous bands (Fig. 2A). The ductal epithelium was 
relatively intact despite the periductal dense inflammatory 
cell infiltrate (Fig. 2B). Obliterative phlebitis was frequently Han Suk Ryu, et al. IgG4-related sclerosing cholangitis  77
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Figure 1. Histologic features of the biopsied liver. (A, B) Lymphoplasmacytic and eosinophilic infiltration in the portal tracts (A: 
H&E, ×200; B: H&E, ×100). The inflammatory cell infiltrates are centered predominantly around the portal veins (arrows), while 
the hepatic artery (white arrowhead) and bile duct epithelia (black arrowhead) are relatively intact without degenerative changes. 
The portal tracts are mildly fibrotic, without an ‘onion-skin’ appearance. Immunohistochemical stain for IgG4 reveals several scattered 
IgG4-positive plasma cells in the portal tracts (C: IgG4 immunostaining, ×400).
noted in the pancreatic parenchyma (Fig. 2C). Immunohisto-
chemistry demonstrated abundant IgG4-positive plasma 
cells with an average of 43 IgG4-positive plasma cells per 
high power field (Fig. 2D). 
DISCUSSION
The discrimination between IgG4-SC and pancreaticobiliary 
malignancies and PSC is an important issue. IgG4-SC 
responds well to steroid therapy or biliary drainage, while 
PSC is progressive and resistant to steroid therapy, resulting 
in the involvement of both the intra-and extrahepatic ducts 
and culminating in biliary cirrhosis.
2 Clinically, PSC usually 
occurs in younger patients and presents with obstructive 
jaundice more commonly than IgG4-SC. PSC is commonly 
associated with inflammatory bowel disease, whereas 
IgG4-SC is associated with autoimmune pancreatitis.
3 The 
measurement of serum IgG4 levels is useful for differentiating 
between these two disorders; according to previous studies, 
increased serum IgG4 levels exceeding 135 mg/dL are frequently 78  The Korean Journal of Hepatology Vol. 17. No. 1, March 2011
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Figure 2. Histologic features of the pancreas (A-C). Diffuse lymphoplasmacytic infiltration of the pancreatic lobules and periductal 
areas with marked septal fibrosis is seen (A: H&E, ×40). The inflammatory cells infiltrate the periductal areas without destruction 
of the ductal epithelia (B: H&E, ×100). Obliterative phlebitis is frequently seen (arrow), while ductal epithelia and arteries are spared. 
(C: Elastic van Gieson, ×200). Abundant IgG4-positive plasma cells are seen in the pancreatic parenchyma (D: IgG4 immunostaining, 
×400). 
seen in these patients.
4 
Hepatic involvement of IgG4-SC can manifest as an overt 
mass-like lesion or as a mild to moderate portal lymphopla-
smacytic infiltration.
5 Tumefactive lesions characterized by 
diffuse lymphoplasmacytic infiltration and prominent eosino-
philic infiltration have been classified as the “lymphoplasmacytic 
type” of inflammatory pseudotumors by Zen et al,
6 and these 
lesions have been proposed to belong to the spectrum of 
IgG4-related diseases. In addition to the lymphoplasmacytic 
and eosinophilic inflammatory infiltrates, obliterative phlebitis 
and cholangitis with periductal fibrosis have been found to 
be common features. 
The liver pathology of IgG4-SC is different from that of 
PSC in the following aspects. IgG4-SC usually leaves the 
epithelial cells of the bile ducts intact, despite the remarkable 
periluminal inflammatory cell infiltration, while PSC is 
characterized by degenerative bile duct lesions and ductopenia.
7 
The portal inflammatory infiltrate of IgG4-SC consists of a 
dominant proportion of lymphocytes and plasma cells and 
also numerous eosinophils, whereas PSC shows a lesser 
degree of portal inflammation and neutrophilic infiltration.
5 
The periductal “onion-skin” fibrosis formed by well-organized 
lamellated collagen bands seen in PSC is absent in IgG4-SC,
3 
and obliterative phlebitis is more commonly identified in 
IgG4-SC.
5,8 Lobular inflammation composed of lymphocytes 
and scattered plasma cells and eosinophils is a common 
finding in IgG4-SC, while it is significantly less frequently 
seen in PSC.
7 Finally, it is important to demonstrate by 
immunohistochemistry the increased number of IgG4-positive 
plasma cells in the tissue in order to differentiate between 
the two diseases.
There is currently no established scoring criteria for IgG4 Han Suk Ryu, et al. IgG4-related sclerosing cholangitis  79
immunostaining in the biliary tract; however, most reports 
have demonstrated that the number of IgG4-positive plasma 
cells in extrahepatic bile ducts affected by IgG4-SC usually 
exceeds 30 per high-power field.
5 As for the peripheral bile 
ducts of small portal tracts, marked heterogeneity in the 
degree of IgG4-positive plasma cell infiltration has been noted: 
for example, several portal tracts may lack the IgG4-positive 
cells entirely.
7 Nevertheless, although there are discrepancies 
regarding the amount of IgG4-positive plasma cell infiltrates 
seen in small portal tracts obtained by needle biopsies, 
immunohistochemistry for IgG4 is an important part of the 
diagnosis of IgG4-SC, as IgG4-positive plasma cells are 
absent or rare in PSC.
5,7 
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